Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Rijken

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Biological Chemistry|March 25, 1982
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrinM Hoylaerts, D C Rijken, H R Lijnen, et al.
Thrombosis and Haemostasis|December 27, 1982
Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivoD Collen, D C Rijken, J Van Damme, et al.
Biochimica Et Biophysica Acta|September 29, 1979
Purification and partial characterization of plasminogen activator from human uterine tissueD C Rijken, G Wijngaards, M Zaal-de Jong, et al.
Thrombosis Research. Supplement|January 1, 1990
Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cellsD C Rijken, M Otter, J Kuiper, et al.
Thrombosis and Haemostasis|August 13, 1990
Plasminogen activation at low temperatures in plasma samples containing therapeutic concentrations of tissue-type plasminogen activator or other thrombolytic agentsD C Rijken, E Seifried, M M Barrett-Bergshoeff, et al.
Thrombosis and Haemostasis|April 8, 1988
Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1)C Kluft, A F Jie, D C Rijken, et al.
The Journal of Biological Chemistry|December 5, 1988
Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cellsJ Kuiper, M Otter, D C Rijken, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1983
Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assayD C Rijken, I Juhan-Vague, F de Cock, et al.
Thrombosis and Haemostasis|May 11, 1999
Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitroD V Sakharov, M Barrertt-Bergshoeff, R T Hekkenberg, et al.
Clinical Pharmacology and Therapeutics|August 1, 1989
Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjectsP Tanswell, E Seifried, P C Su, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|March 25, 1982
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrinM Hoylaerts, D C Rijken, H R Lijnen, et al.
Thrombosis and Haemostasis|December 27, 1982
Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivoD Collen, D C Rijken, J Van Damme, et al.
Biochimica Et Biophysica Acta|September 29, 1979
Purification and partial characterization of plasminogen activator from human uterine tissueD C Rijken, G Wijngaards, M Zaal-de Jong, et al.
Thrombosis Research. Supplement|January 1, 1990
Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cellsD C Rijken, M Otter, J Kuiper, et al.
Thrombosis and Haemostasis|August 13, 1990
Plasminogen activation at low temperatures in plasma samples containing therapeutic concentrations of tissue-type plasminogen activator or other thrombolytic agentsD C Rijken, E Seifried, M M Barrett-Bergshoeff, et al.
Thrombosis and Haemostasis|April 8, 1988
Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1)C Kluft, A F Jie, D C Rijken, et al.
The Journal of Biological Chemistry|December 5, 1988
Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cellsJ Kuiper, M Otter, D C Rijken, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1983
Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assayD C Rijken, I Juhan-Vague, F de Cock, et al.
Thrombosis and Haemostasis|May 11, 1999
Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitroD V Sakharov, M Barrertt-Bergshoeff, R T Hekkenberg, et al.
Clinical Pharmacology and Therapeutics|August 1, 1989
Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjectsP Tanswell, E Seifried, P C Su, et al.
Pageof 11